2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VISSIT Intracranial Stent Study for Ischemic Therapy Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel), Aspirin and Clopidogrel (Medical therapy) - Ischemic Stroke, Transient Ischemic Attack | Phase 2 / Phase 3 | Terminated | Codman & Shurtleff | 125 | 2008-10-01 | 2015-02-20 |
| E-Selectin Nasal Spray to Prevent Stroke Recurrence E-Selectin nasal spray - Cerebrovascular Accident, Transient Ischemic Attack | Phase 2 | Terminated | National Institute of Neurological Disorders and Stroke (NINDS) | 60 | 2001-03-01 | 2010-05-04 |
Camurati-Engelmann Syndrome (1) · Ischemic Stroke (1) · Stroke (1)
Brain Diseases (2) · Brain Ischemia (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Musculoskeletal Diseases (1) · Osteochondrodysplasias (1) · Stroke (1)
Aspirin (1) · Clopidogrel (1)
Codman & Shurtleff (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
United States (1)